These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26043680)

  • 1. Effects of expiring reimbursability of pentaerythrityl tetranitrate (PETN, pentalong®) on anti-anginal therapy: an observational study.
    Grimmsmann T; Chenot JF; Angelow A
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):803-11. PubMed ID: 26043680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany.
    Icks A; Haastert B; Rathmann W; Schröder-Bernhardi D; Giani G
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):516-23. PubMed ID: 17907594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and status of nitrate therapy in East Germany].
    Engelmann L; Wetzler G; Kucher A; Frömmel H
    Z Kardiol; 1989; 78 Suppl 2():99-101; discussion 115-7. PubMed ID: 2511700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with NO donors-antiatherogenic and antioxidant actions].
    Grosser N; Schröder H
    Herz; 2004 Feb; 29(1):116-22. PubMed ID: 14968347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial.
    Münzel T; Meinertz T; Tebbe U; Schneider HT; Stalleicken D; Wargenau M; Gori T; Klingmann I;
    Eur Heart J; 2014 Apr; 35(14):895-903. PubMed ID: 24071762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of short- and long-acting nitrates in stable angina pectoris.
    Kosmicki MA
    Curr Clin Pharmacol; 2009 May; 4(2):132-41. PubMed ID: 19442078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antianginal effects of pentaerythritol tetranitrate.
    Arce-Gomez E; Aspe y Rosas J; Alcocer Diaz Barreiro L; Diaz Barreiro AL
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2487-91. PubMed ID: 6775303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate.
    Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of pentaerythritol tetranitrate in two doses in patients with stable angina pectoris].
    Kośmicki MA; Malczewska B; Sadowski Z
    Przegl Lek; 2005; 62(1):8-12. PubMed ID: 16053212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PETN: long acting nitrate with tolerance devoiding properties and innovative potential].
    Richartz BM; Schneider HT; Silber S
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():43-7. PubMed ID: 18540332
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term effect of various nitrates in ischemic heart disease and latent heart failure].
    Assmann I; Dueck KD
    Z Kardiol; 1989; 78 Suppl 2():68-71; discussion 115-7. PubMed ID: 2511696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C.
    Dikalov S; Fink B; Skatchkov M; Bassenge E
    Free Radic Biol Med; 1999 Jul; 27(1-2):170-6. PubMed ID: 10443933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the effect of nitroglycerine and pentaerithritol compositum on exercise time restricted by anginal pain or objective parameters of ischaemia in patients with stable angina].
    Siński M; Lewandowski J; Abramczyk P; Nowosad H; Grzelak-Szafrańiska H
    Pol Arch Med Wewn; 2005 Aug; 114(2):755-60. PubMed ID: 16808313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentaerythrityl tetranitrate (PETN): a better nitrate?
    Rutherford E; Struthers AD
    Eur Heart J; 2019 Dec; 40(46):e23-e25. PubMed ID: 24126881
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 20. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.